Patents by Inventor Jaemoon Lee

Jaemoon Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11228985
    Abstract: An electronic device according to various embodiments may include: at least one antenna; and at least one communication processor configured to support first network communication with a first network and second network communication with a second network different from the first network.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: January 18, 2022
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Jaemoon Cha, Seonyun Kim, Yeonjoo Lee, Suyoung Park, Sunmin Hwang
  • Publication number: 20210347779
    Abstract: We provide compounds given by Formula I, which is shown in FIG. 3, or pharmaceutically acceptable salts thereof, as well as formulations thereof and methods of use of those compounds and formulations for treatment of cancer.
    Type: Application
    Filed: January 5, 2021
    Publication date: November 11, 2021
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Wanjun ZHENG, Xiaojie ZHU, Hong DU, Maarten POSTEMA, Yimin JIANG, Jing LI, Robert YU, Hyeong-Wook CHOI, Jaemoon LEE, Francis G. FANG, Daniel CUSTAR
  • Publication number: 20210326092
    Abstract: A display apparatus is disclosed. The display apparatus includes at least one display module; a first interface configured to receive a first signal from a first display apparatus; a second interface configured to receive a second signal from a second display apparatus; and a processor configured to: repeatedly execute a first operation for identifying the first signal received through the first interface and a second operation for identifying the second signal received through the second interface, based on the first signal being identified while executing the first operation, display an image on the at least one display module based on the first signal received through the first interface without executing the second operation, and based on the second signal being identified while executing the second operation, display the image on the at least one display module based on the second signal received through the second interface without executing the first operation.
    Type: Application
    Filed: September 23, 2020
    Publication date: October 21, 2021
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Deukgeun Ahn, Jaemoon Lee
  • Patent number: 11145263
    Abstract: Disclosed is a display apparatus. The display apparatus includes a liquid crystal panel including a plurality of subpixels, a backlight unit including a white light source and a blue light source, and a processor configured to adjust the blue light source to emit light and to adjust an aperture ratio of at least one of the plurality of subpixels based on a color temperature of the white light source and a target color temperature.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: October 12, 2021
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Minhoon Lee, Jaemoon Lee
  • Publication number: 20210295794
    Abstract: A display device is disclosed. The display device comprises: a display panel including a plurality of pixels; a gate driver for applying a gate-on signal through a plurality of gate lines of the display panel; a data driver for applying a data signal through a plurality of data lines of the display panel; and a timing controller for controlling the gate driver and the data driver to display an image frame at a first frame frequency, wherein the display panel is driven at a second frame frequency that is higher than the first frame frequency, and the timing controller controls the gate-on signal to be applied to the plurality of gate lines for a time determined on the basis of the second frame frequency, and controls the data driver to apply an over driven data signal to the plurality of data lines.
    Type: Application
    Filed: April 16, 2019
    Publication date: September 23, 2021
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Minhoon LEE, Jaemoon LEE, Byungkwan KIM, Changhun KIM, Sungjin LIM
  • Patent number: 11079796
    Abstract: An electronic device includes a cover glass, a back cover, a side member that surrounds a space between the cover glass and the back cover, wherein at least a portion of the side member is formed of a conductive member, a support member that is extended from the side member and includes at least one opening, a first printed circuit board that is interposed between the support member and the back cover or between the support member and the cover glass, a second printed circuit board that is interposed between the first printed circuit board and the back cover or between the first printed circuit board and the cover glass, an electrical component that is positioned on the first printed circuit board, and a wireless communication circuit that is positioned on the second printed circuit board.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: August 3, 2021
    Inventors: Jaewon Choe, Kyungmoon Seol, Jaemoon Lee, Jungkyu Lee
  • Publication number: 20210188867
    Abstract: The invention provides methods for the synthesis of eribulin or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate) through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Homer-Wadsworth-Emmons olefination), Dieckmann reaction, catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic intermediate. The invention also provides compounds useful as intermediates in the synthesis of eribulin or a pharmaceutically acceptable salt thereof and methods for preparing the same.
    Type: Application
    Filed: March 1, 2021
    Publication date: June 24, 2021
    Applicants: EISAI R&D MANAGEMENT CO., LTD., EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Francis G. FANG, Dae-Shik KIM, Hyeong-Wook CHOI, Charles E. CHASE, Jaemoon LEE
  • Patent number: 10941148
    Abstract: We provide compounds given by Formula I, which is shown in FIG. 3, or pharmaceutically acceptable salts thereof, as well as formulations thereof and methods of use of those compounds and formulations for treatment of cancer.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: March 9, 2021
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Wanjun Zheng, Xiaojie Zhu, Hong Du, Maarten Postema, Yimin Jiang, Jing Li, Robert Yu, Hyeong-wook Choi, Jaemoon Lee, Frank Fang, Daniel Custar
  • Patent number: 10934307
    Abstract: The invention provides methods for the synthesis of eribulin or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate) through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Horner-Wadsworth-Emmons olefination), Dieckmann reaction, catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic intermediate. The invention also provides compounds useful as intermediates in the synthesis of eribulin or a pharmaceutically acceptable salt thereof and methods for preparing the same.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: March 2, 2021
    Assignee: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Francis G. Fang, Dae-Shik Kim, Hyeong-Wook Choi, Charles E. Chase, Jaemoon Lee
  • Publication number: 20200228808
    Abstract: An electronic apparatus and a controlling method thereof are provided.
    Type: Application
    Filed: January 14, 2020
    Publication date: July 16, 2020
    Inventors: Jaemoon LEE, Minhoon LEE
  • Publication number: 20200223864
    Abstract: The invention provides methods for the synthesis of eribulin or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate) through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Horner-Wadsworth-Emmons olefination), Dieckmann reaction, catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic intermediate. The invention also provides compounds useful as intermediates in the synthesis of eribulin or a pharmaceutically acceptable salt thereof and methods for preparing the same.
    Type: Application
    Filed: March 30, 2020
    Publication date: July 16, 2020
    Inventors: Francis G. FANG, Dae-Shik KIM, Hyeong-Wook CHOI, Charles E. CHASE, Jaemoon LEE
  • Publication number: 20200160802
    Abstract: Disclosed is a display apparatus. The display apparatus includes a liquid crystal panel including a plurality of subpixels, a backlight unit including a white light source and a blue light source, and a processor configured to adjust the blue light source to emit light and to adjust an aperture ratio of at least one of the plurality of subpixels based on a color temperature of the white light source and a target color temperature.
    Type: Application
    Filed: November 8, 2019
    Publication date: May 21, 2020
    Inventors: Minhoon LEE, Jaemoon LEE
  • Patent number: 10611773
    Abstract: The invention provides methods for the synthesis of eribulin or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate) through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Horner-Wadsworth-Emmons olefination), Dieckmann reaction, catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic intermediate. The invention also provides compounds useful as intermediates in the synthesis of eribulin or a pharmaceutically acceptable salt thereof and methods for preparing the same.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: April 7, 2020
    Assignee: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Francis G. Fang, Dae-Shik Kim, Hyeong-Wook Choi, Charles E. Chase, Jaemoon Lee
  • Publication number: 20190384358
    Abstract: An electronic device includes a cover glass, a back cover, a side member that surrounds a space between the cover glass and the back cover, wherein at least a portion of the side member is formed of a conductive member, a support member that is extended from the side member and includes at least one opening, a first printed circuit board that is interposed between the support member and the back cover or between the support member and the cover glass, a second printed circuit board that is interposed between the first printed circuit board and the back cover or between the first printed circuit board and the cover glass, an electrical component that is positioned on the first printed circuit board, and a wireless communication circuit that is positioned on the second printed circuit board.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Jaewon CHOE, Kyungmoon SEOL, Jaemoon LEE, Jungkyu LEE
  • Publication number: 20190315754
    Abstract: We provide compounds given by Formula I, which is shown in FIG. 3, or pharmaceutically acceptable salts thereof, as well as formulations thereof and methods of use of those compounds and formulations for treatment of cancer.
    Type: Application
    Filed: April 23, 2019
    Publication date: October 17, 2019
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Wanjun Zheng, Xiaojie Zhu, Hong Du, Maarten Postema, Yimin Jiang, Jing Li, Robert Yu, Hyeong-wook Choi, Jaemoon Lee, Frank Fang, Daniel Custar
  • Patent number: 10398009
    Abstract: The present disclosure relates to a lighting device based on scenario-activation using a push service, and a push server, a control device and a communication device for controlling the lighting device. In one embodiment of the present disclosure, a push server for controlling a lighting device based on scenario-activation using a push service, may include: a communication unit for receiving a control message, based on a first communication protocol, from a control device and for transmitting the received control message to either a communication device or a push gateway based on the first communication protocol; a control message storage unit for storing, therein, the control message; a communication device-identification storage unit for storing, therein, identifications of communication devices to receive the control message; and, a control unit configured for controlling the communication unit, the control message storage unit, and the communication device-identification storage unit.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: August 27, 2019
    Assignee: LG ELECTRONICS INC.
    Inventors: Seunghyup Noh, Jaemoon Lee, Kyungtae Ro, Jae Myoung Lee
  • Patent number: 10316040
    Abstract: We provide compounds given by Formula I, which is shown in FIG. 3, or pharmaceutically acceptable salts thereof, as well as formulations thereof and methods of use of those compounds and formulations for treatment of cancer.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: June 11, 2019
    Assignee: Eisai R&D Management Co., LTD.
    Inventors: Wanjun Zheng, Xiaojie Zhu, Hong Du, Maarten Postema, Yimin Jiang, Jing Li, Robert Yu, Hyeong-wook Choi, Jaemoon Lee, Frank Fang, Daniel Custar
  • Publication number: 20190144463
    Abstract: The invention provides methods for the synthesis of eribulin or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate) through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Horner-Wadsworth-Emmons olefination), Dieckmann reaction, catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic intermediate. The invention also provides compounds useful as intermediates in the synthesis of eribulin or a pharmaceutically acceptable salt thereof and methods for preparing the same.
    Type: Application
    Filed: January 14, 2019
    Publication date: May 16, 2019
    Inventors: Francis G. FANG, Dae-Shik KIM, Hyeong-Wook CHOI, Charles E. CHASE, Jaemoon LEE
  • Patent number: D905904
    Type: Grant
    Filed: April 3, 2019
    Date of Patent: December 22, 2020
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventor: Jaemoon Lee
  • Patent number: D905905
    Type: Grant
    Filed: April 3, 2019
    Date of Patent: December 22, 2020
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventor: Jaemoon Lee